Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Endometrial Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

M D Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Pamela Soliman, MD) · psoliman@mdanderson.org · 713-745-2352
Contact: Principal Investigator (Pamela Soliman, MD)

Study leads

Pamela Soliman, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

Endometrial Cancer · Stage III Endometrial Cancer · Stage III Endometrial Carcinoma

Abroad (travel likely)RecruitingEARLY_PHASE1

Basking Ridge, United States · Middletown, United States

Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

Endometrioid Endometrial Cancer

Abroad (travel likely)RecruitingPHASE2

Hangzhou, China

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Neoplasms

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Palo Alto, United States

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

High Grade Epithelial Ovarian Cancer · High Grade Serous Ovarian Cancer · Primary Peritoneal Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Tucson, United States